Estrogen and insulin synergistically promote type 1 endometrial cancer progression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Estrogen and insulin synergistically promote type 1 endometrial cancer progression

Published:2017-11-27 Issue:12 Volume:18 Page:1000-1010
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Tian Wenyan¹,Teng Fei¹,Zhao Jing¹,Gao Jinping¹,Gao Chao¹,Sun Dandan¹,Liu Guoyan¹,Zhang Yanfang¹,Yu Shizhu²,Zhang Wei³,Wang Yingmei¹,Xue Fengxia¹

Affiliation:

1. Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China

2. Department of Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China

3. Department of Cancer Biology, Comprehensive Cancer Center of Wake Forest Baptist Medical Center, Winston-Salem, NC, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2017.1394547

Reference25 articles.

1. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC)

2. Two pathogenetic types of endometrial carcinoma

3. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line

4. Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers

5. Cancer statistics in China, 2015

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma Proteomic Signature of Endometrial Cancer in Patients with Diabetes;ACS Omega;2024-01-18

2. Mechanism of cryptotanshinone to improve endocrine and metabolic functions in the endometrium of PCOS rats;Journal of Ethnopharmacology;2024-01

3. Endometrial Carcinoma. Low-Grade Endometrioid Carcinoma;Gynecologic and Obstetric Pathology;2024

4. A prospective study of circulating estrogen in oral leukoplakia and oral squamous cell carcinoma;Journal of Cancer Research and Therapeutics;2023-12-15

5. Glucose metabolic reprogramming and its therapeutic potential in obesity-associated endometrial cancer;Journal of Translational Medicine;2023-02-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3